A Model for the Origin of TCR-alphabeta+ CD4-CD8- B220+ Cells Based on High Affinity TCR Signals
Overview
Affiliations
The origin of TCR-alphabeta+ CD4-CD8- cells is unclear, yet accumulating evidence suggests that they do not represent merely a default pathway of unselected thymocytes. Rather, they arise by active selection as evidenced by their absence in mice lacking expression of class I MHC. TCR-alphabeta+ CD4-CD8- cells also preferentially accumulate in mice lacking expression of Fas/APO-1/CD95 (lpr) or Fas-ligand (gld), suggesting that this subset might represent a subpopulation destined for apoptosis in normal mice. Findings from mice bearing a self-reactive TCR transgene support this view. In the current study we observe that in normal mice, TCR-alphabeta+ CD4-CD8- thymocytes contain a high proportion of cells undergoing apoptosis. The apoptotic subpopulation is further identified by its expression of B220 and IL2Rbeta and the absence of surface CD2. The CD4-CD8- B220+ phenotype is also enriched in T cells that recognize endogenous retroviral superantigens, and can be induced in TCR transgenic mice using peptide/MHC complexes that bear high affinity, but not low affinity, for TCR. A model is presented whereby the TCR-alphabeta+ CD2- CD4-CD8- B220+ phenotype arises from high intensity TCR signals. This model is broadly applicable to developing thymocytes as well as mature peripheral T cells and may represent the phenotype of self-reactive T cells that are increased in certain autoimmune conditions.
Xu T, Xu Q, Lu R, Oakland D, Li S, Li L Sci Rep. 2024; 14(1):31158.
PMID: 39732739 PMC: 11682054. DOI: 10.1038/s41598-024-82406-7.
Yero A, Shi T, Clain J, Zghidi-Abouzid O, Racine G, Costiniuk C Viruses. 2024; 16(10).
PMID: 39459942 PMC: 11512404. DOI: 10.3390/v16101609.
Immune profiling analysis of double-negative T cells in patients with systemic sclerosis.
Zhang D, Alip M, Chen H, Wu D, Zhu H, Han Y Clin Rheumatol. 2024; 43(5):1623-1634.
PMID: 38436769 DOI: 10.1007/s10067-024-06920-9.
Kalusche W, Case C, Taylor E Clin Sci (Lond). 2023; 137(23):1771-1785.
PMID: 38031726 PMC: 10721433. DOI: 10.1042/CS20230924.
Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy.
Yam A, Bailey J, Lin F, Jakovija A, Youlten S, Counoupas C Cancer Res. 2023; 83(8):1315-1328.
PMID: 36787115 PMC: 10102850. DOI: 10.1158/0008-5472.CAN-21-4025.